12:07 PM EST - Oncolytics Biotech Inc : Provided an enrollment update on the phase 1/2 GOBLET study in a poster presentation at the 2022 American Society of Clinical Oncology Gastrointestinal Cancers Symposium. Oncolytics Biotech Inc
shares T.ONC are trading up $0.20 at $2.48.
